CytomX Therapeutics (CTMX) Interest Coverage Ratio Growth (5y) (2019 - 2025)
CytomX Therapeutics (CTMX) Interest Coverage Ratio Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43.02% |
| Sep 30, 2025 | 31.13% |
| Jun 30, 2025 | 58.62% |
| Mar 31, 2025 | 24.58% |
| Dec 31, 2024 | 16.44% |
| Sep 30, 2024 | 15.40% |
| Jun 30, 2024 | 39.43% |
| Mar 31, 2024 | 17.27% |
| Dec 31, 2023 | 83.20% |
| Sep 30, 2023 | 14.97% |
| Dec 31, 2022 | -178.78% |
| Sep 30, 2022 | -154.52% |
| Jun 30, 2022 | -35.65% |
| Mar 31, 2022 | -160.30% |
| Dec 31, 2021 | 6.13% |
| Sep 30, 2021 | -49.09% |
| Jun 30, 2021 | -62.91% |
| Mar 31, 2021 | -107.84% |
| Dec 31, 2020 | 9.21% |
| Sep 30, 2020 | -10.06% |